rekrunner wrote:
casual obsever wrote:
In addition, Schumacher has made plenty observations of various blood tests of elite runners and their performances over an extended period of time. The AIU continues to rely on his expertise, which thus far was always accepted by CAS.
Yes, that is the very same professor who "estimated" based on his experiences that blood doping alone may provide a boost of up to one minute over 10,000 m.
You've said this several times, so I have no doubt you actually believe it.
The AIU relies on his anti-doping expertise in anti-doping cases.
Schumacher was being asked in the Karamasheva CAS hearing (2017/0/5268) what the performance benefit could be with EPO. His statement on the record goes like this: EPO "can increase oxygen supply by 6% and take as much as one minute off the time taken to run 10,000 meters, and proportionately more over lesser distances."
The arbitrator wants to know if there's a performance enhancement benefit with EPO in some of these ABP cases. It helps with the "unfair advantage" clause when times, awards, medals, titles, etc. are going to be annulled over the time period of the hematological anomalies detected on the passport - particularly at or near key competitions. Remember Kiptum had wiped from the slate the HM WR & Dubai marathon 2nd place finish (2:04) with anomalies detected at those competitions. No IC EPO positive but a 99.99 specificity on the anamolies (less than 1 in 10,000 chance of being undoped).
So, the AIU/CAS not only relies on his anti-doping expertise but his opinion on the performance benefits of EPO/blood transfusions.